Fas (APO-1/CD95), a member of the tumor necrosis factor receptor (TNFR)/nerve growth factor receptor (NGFR) superfamily, is a cell-surface molecule that induces apoptosis upon activation. Fas-associated phosphatase-1 (FAP-1) is a 250-kDa protein tyrosine phosphatase (PTP) that is associated with the negative regulatory domain of Fas (C-terminal 15 amino acids). Human tumor cell lines become resistant to Fas-mediated apoptosis when transfected with FAP-1, indicating that FAP-1 functions as a negative regulator in Fas-mediated death signaling. However, the mechanisms by which FAP-1 inhibits apoptosis are still unclear. In order to determine how FAP-1 affects the signaling mediated by Fas, we set out to identify substrates of FAP-1. Toward this end, we prepared synthetic proteins with either the catalytic domain of FAP-1 (C-terminal 399 amino acids) or its inactive form (Cys2408-->Ser) fused to glutathione-S-transferase (GST). Using an in vitro dephosphorylation reaction, we found that FAP-1 dephosphorylates IkappaBalpha. Furthermore, a substrate trapping mutant was found to bind tyrosine-phosphorylated IkappaBalpha. Taken together, our data confirm that IkappaBalpha is a substrate of FAP-1.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1432-1327.2000.01818.xDOI Listing

Publication Analysis

Top Keywords

ikappabalpha substrate
12
fap-1
9
fas-associated phosphatase-1
8
factor receptor
8
amino acids
8
identification ikappabalpha
4
substrate fas-associated
4
phosphatase-1 fas
4
fas apo-1/cd95
4
apo-1/cd95 member
4

Similar Publications

Mitoxantrone attenuates lipopolysaccharide-induced acute lung injury via inhibition of NEDD8 activating enzyme.

Int Immunopharmacol

December 2024

Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China; Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China. Electronic address:

Background: Lipopolysaccharide (LPS) triggers the activation of nuclear factor kappa B (NF-κB) by interacting with Toll-like receptor 4 (TLR4), leading to the production of various proinflammatory enzymes and cytokines that are crucial in the development of acute lung injury (ALI). Mitoxantrone (MTX) has been demonstrated to mitigate the inflammatory response caused by LPS; however, its precise function in the context of ALI is not fully comprehended.

Purpose: This study aimed to investigate the inhibitory effects and underlying mechanisms of MTX against LPS-induced ALI.

View Article and Find Full Text PDF
Article Synopsis
  • The Huashi Baidu Formula (HBF) shows promise in treating COVID-19 and may have protective effects on acute kidney injury (AKI), though further research is needed to clarify its mechanisms.
  • A study assessed HBF's effects on AKI using a mouse model and employed various biochemical and molecular analyses to uncover its potential benefits and active ingredients.
  • Results indicated that HBF treatment significantly improved kidney function and reduced markers of inflammation and damage, while also enhancing protective factors in the kidneys.
View Article and Find Full Text PDF

Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathway.

Cell Rep

October 2024

Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China. Electronic address:

Article Synopsis
  • - PLK2 is an important protein kinase linked to brain cell function and is identified as a key early-response gene when microglial cells are stimulated by lipopolysaccharide (LPS).
  • - Inhibition or knockdown of PLK2 reduces the production of proinflammatory factors by blocking the IKKβ-NF-κB signaling pathway, and HSP90α is discovered as a new target of PLK2 that helps regulate this process.
  • - Studies in a mouse model of Parkinson's disease show that removing PLK2 from microglial cells significantly reduces neuroinflammation and protects dopaminergic neurons from damage.
View Article and Find Full Text PDF

Isoorientin (ISO), a flavone C-glycoside, is a glycogen synthase kinase 3β (GSK3β) substrate-competitive inhibitor. ISO has potential in treatment of Alzheimer's disease (AD). An excessive activation of GSK3β can lead to neuroinflammation causing neuronal damage.

View Article and Find Full Text PDF

Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates.

Nat Commun

September 2024

Biotechnology and Cell Signaling (CNRS/Université de Strasbourg, UMR7242), Ecole Superieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, 67400, Illkirch, France.

Article Synopsis
  • Researchers discovered a specific motif (YDDΦxΦ) in NF-κB pathway substrates that helps these substrates dock with IKK dimers, showing a link between how well they bind and IKK activity, particularly in IκBα phosphorylation and degradation.
  • The study suggests that a certain phosphorylation event on this motif reduces its ability to dock with IKK, which can influence NF-κB signaling, and also indicates that disrupting IKK dimerization disrupts substrate binding.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!